Amanote Research
Register
Sign In
Corrrection: Article on Cardiac Toxicity and Trastuzumab Combined With Pertuzumab
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-14-11-cor
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
June 1, 2008
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Pertuzumab and Trastuzumab: The Rationale Way to Synergy
Anais da Academia Brasileira de Ciencias
Multidisciplinary
Safety Assessment of Neoadjuvant Pertuzumab Combined With Trastuzumab in Nonmetastatic HER2-Positive Breast Cancer in Postmenopausal Elderly Women of South Asia
International Journal of Breast Cancer
Cancer Research
Oncology
Pharmacology
Skin/Nail Infections With the Addition of Pertuzumab to Trastuzumab-Based Chemotherapy
Breast Cancer Research and Treatment
Cancer Research
Oncology
Pcn163 - Cost-Effectiveness of Add-On Pertuzumab Combined With Trastuzumab and Docetaxel Versus Placebo as Treatment of Her-2 Positive Metastatic Breast Cancer in Czech Republic
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Correction: Cryo-Em Structure of HER2-trastuzumab-pertuzumab Complex
PLoS ONE
Multidisciplinary
Evaluation of Radiation-Induced Cardiac Toxicity in Breast Cancer Patients Treated With Trastuzumab-Based Chemotherapy
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Patient With Metastatic Breast Cancer, HER2-positive, Trastuzumab- And Pertuzumab-Resistant Responding to Lapatinib
AboutOpen
Tumor Infiltrating Lymphocytes in Patients Receiving Trastuzumab/Pertuzumab-Based Chemotherapy: A TRYPHAENA Substudy
European Journal of Cancer
Cancer Research
Oncology
Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab With Taxane for Human Epidermal Growth Factor Receptor 2–positive Advanced Breast Cancer: Final Results From MARIANNE
Cancer
Cancer Research
Oncology
